Shanghai Fosun Pharmaceutical(02196): Liu Yi elected as executive director
Fosun Pharma (02196) announced that Mr. Liu Yi was officially elected as an executive director of the 10th board of directors at the extraordinary general meeting of shareholders, appointed to take effect from December 2, 2025, until the end of the current term of the board of directors.
Shanghai Fosun Pharmaceutical (02196) announced that Mr. Liu Yi was formally elected as an executive director of the tenth board of directors at the extraordinary shareholders' meeting, with his appointment effective from December 2, 2025 until the end of this term of the board of directors.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
